Skip to main content

Infant Development

1
Pipeline Programs
8
Companies
13
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
5 programs
1
transcutaneous auricular vagus nerve stimulationPhase 11 trial
Mobile HealthN/A
Music EnhancementN/A1 trial
Systematic introduction of taste portionsN/A1 trial
smartphone application to promote nurturing careN/A
Active Trials
NCT02936284Completed94Est. Jul 2021
NCT02634749Completed250Est. Apr 2019
NCT05101707Completed6Est. Feb 2024
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
2 programs
Blueberry PowderN/A1 trial
Iron in infant formulaN/A1 trial
Active Trials
NCT05006989Completed75Est. Mar 2025
NCT03828708Unknown30Est. May 2024
Abbott
AbbottABBOTT PARK, IL
2 programs
Experimental Infant FormulaN/A1 trial
Experimental Infant FormulaN/A1 trial
Active Trials
NCT04006236Completed245Est. Sep 2021
NCT03991949Completed51Est. Nov 2022
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
2 programs
Mobile HealthN/A2 trials
smartphone application to promote nurturing careN/A1 trial
Active Trials
NCT07742891Not Yet Recruiting50Est. Dec 2028
NCT06195358Completed220Est. Aug 2026
NCT05106894Completed41Est. Aug 2024
Alliance Pharmaceuticals
2 programs
pacifier-activated deviceN/A1 trial
smartphone application to promote nurturing careN/A
Active Trials
NCT03230032Completed130Est. Jul 2021
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Lower protein formula; Higher protein formulaN/A1 trial
Active Trials
NCT00338689Unknown1,678Est. Dec 2024
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Prone PositionerN/A1 trial
Active Trials
NCT06018064RecruitingEst. Sep 2028

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Human BioSciencestranscutaneous auricular vagus nerve stimulation
Angeles TherapeuticsMobile Health
Angeles TherapeuticsMobile Health
City TherapeuticsProne Positioner
Angeles Therapeuticssmartphone application to promote nurturing care
Colorado TherapeuticsIron in infant formula
Colorado TherapeuticsBlueberry Powder
AbbottExperimental Infant Formula
AbbottExperimental Infant Formula
Alliance Pharmaceuticalspacifier-activated device
Human BioSciencesMusic Enhancement
Human BioSciencesSystematic introduction of taste portions
UNION therapeuticsLower protein formula; Higher protein formula

Clinical Trials (13)

Total enrollment: 2,870 patients across 13 trials

NCT05101707Human BioSciencestranscutaneous auricular vagus nerve stimulation

CIMT and taVNS for Hemiplegia in Infants

Start: Apr 2022Est. completion: Feb 20246 patients
Phase 1Completed
NCT07742891Angeles TherapeuticsMobile Health

ReSeT in ALL 2: A Randomized, Controlled Pilot Trial Testing an Optimized, Multi-component Mobile Health Intervention to Reduce Sedentary Time in Early Adolescents and Young Adults (eAYAs) With ALL During Maintenance Therapy

Start: Sep 2026Est. completion: Dec 202850 patients
N/ANot Yet Recruiting
NCT06195358Angeles TherapeuticsMobile Health

Mobile Health Intervention for Infants in Guatemala (18-m Intervention)

Start: Jan 2024Est. completion: Aug 2026220 patients
N/ACompleted
NCT06018064City TherapeuticsProne Positioner

Investigating Fit and Satisfaction of the Prone Positioner

Start: Sep 2023Est. completion: Sep 2028
N/ARecruiting
NCT05106894Angeles Therapeuticssmartphone application to promote nurturing care

Mobile Health Intervention to Promote Positive Infant Health Outcomes in Guatemala

Start: Jan 2023Est. completion: Aug 202441 patients
N/ACompleted
NCT03828708Colorado TherapeuticsIron in infant formula

Early Iron Exposure on the Gut Microbiota in Young Infants

Start: Sep 2021Est. completion: May 202430 patients
N/AUnknown
NCT05006989Colorado TherapeuticsBlueberry Powder

Blueberry Intake and Infant Gut Health

Start: Sep 2021Est. completion: Mar 202575 patients
N/ACompleted
NCT03991949AbbottExperimental Infant Formula

Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula

Start: Oct 2019Est. completion: Nov 202251 patients
N/ACompleted
NCT04006236AbbottExperimental Infant Formula

Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas

Start: Aug 2019Est. completion: Sep 2021245 patients
N/ACompleted
NCT03230032Alliance Pharmaceuticalspacifier-activated device

Pacifier Activated Device and Mother's Voice in Infants at High-risk for Cerebral Palsy

Start: Jun 2017Est. completion: Jul 2021130 patients
N/ACompleted
NCT02936284Human BioSciencesMusic Enhancement

Infant Environment Study

Start: Nov 2016Est. completion: Jul 202194 patients
N/ACompleted
NCT02634749Human BioSciencesSystematic introduction of taste portions

OTIS - Optimized Complementary Feeding Study

Start: Apr 2015Est. completion: Apr 2019250 patients
N/ACompleted
NCT00338689UNION therapeuticsLower protein formula; Higher protein formula

European Childhood Obesity Project: Early Programming by Infant Nutrition?

Start: Oct 2002Est. completion: Dec 20241,678 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 2,870 patients
8 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.